Daiwa Securities Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7K | Hold |
209
| – | – | ﹤0.01% | 1137 |
|
2025
Q1 | $7K | Hold |
209
| – | – | ﹤0.01% | 1115 |
|
2024
Q4 | $8K | Hold |
209
| – | – | ﹤0.01% | 1136 |
|
2024
Q3 | $7K | Buy |
209
+52
| +33% | +$1.74K | ﹤0.01% | 1153 |
|
2024
Q2 | $4K | Sell |
157
-60
| -28% | -$1.53K | ﹤0.01% | 1209 |
|
2024
Q1 | $7K | Hold |
217
| – | – | ﹤0.01% | 1182 |
|
2023
Q4 | $6K | Hold |
217
| – | – | ﹤0.01% | 1189 |
|
2023
Q3 | $6K | Hold |
217
| – | – | ﹤0.01% | 1142 |
|
2023
Q2 | $7K | Hold |
217
| – | – | ﹤0.01% | 1151 |
|
2023
Q1 | $8K | Hold |
217
| – | – | ﹤0.01% | 1118 |
|
2022
Q4 | $8K | Buy |
217
+35
| +19% | +$1.29K | ﹤0.01% | 1120 |
|
2022
Q3 | $6K | Hold |
182
| – | – | ﹤0.01% | 1149 |
|
2022
Q2 | $5K | Hold |
182
| – | – | ﹤0.01% | 1165 |
|
2022
Q1 | $6K | Hold |
182
| – | – | ﹤0.01% | 1159 |
|
2021
Q4 | $5K | Hold |
182
| – | – | ﹤0.01% | 1196 |
|
2021
Q3 | $5K | Buy |
182
+83
| +84% | +$2.28K | ﹤0.01% | 1177 |
|
2021
Q2 | $3K | Hold |
99
| – | – | ﹤0.01% | 1115 |
|
2021
Q1 | $3K | Hold |
99
| – | – | ﹤0.01% | 1120 |
|
2020
Q4 | $2K | Sell |
99
-197
| -67% | -$3.98K | ﹤0.01% | 1137 |
|
2020
Q3 | $6K | Hold |
296
| – | – | ﹤0.01% | 1070 |
|
2020
Q2 | $5K | Hold |
296
| – | – | ﹤0.01% | 1092 |
|
2020
Q1 | $5K | Hold |
296
| – | – | ﹤0.01% | 1092 |
|
2019
Q4 | $7K | Sell |
296
-36
| -11% | -$851 | ﹤0.01% | 1078 |
|
2019
Q3 | $9K | Hold |
332
| – | – | ﹤0.01% | 1028 |
|
2019
Q2 | $11K | Hold |
332
| – | – | ﹤0.01% | 1036 |
|
2019
Q1 | $12K | Buy |
332
+49
| +17% | +$1.77K | ﹤0.01% | 1014 |
|
2018
Q4 | $9K | Hold |
283
| – | – | ﹤0.01% | 995 |
|
2018
Q3 | $14K | Hold |
283
| – | – | ﹤0.01% | 1002 |
|
2018
Q2 | $17K | Sell |
283
-68,700
| -100% | -$4.13M | ﹤0.01% | 1007 |
|
2018
Q1 | $3.16M | Buy |
+68,983
| New | +$3.16M | 0.03% | 299 |
|